Valiant LaboratoriesNSE:VALIANTLAB -0.06%51 Days Inventory is 57.47 as of Mar. 2026, which is 184% above its 10-year median of 20.21. GuruFocus rates NSE:VALIANTLAB with a GF Score™ of 51/100 and a GF Value™ of ₹104.87 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 916 Drug Manufacturers companies, Valiant Laboratories ranks better than 94.65% on this metric.
The historical rank and industry rank for Valiant Laboratories's Days Inventory or its related term are showing as below:
NSE:VALIANTLAB'
s Days Inventory Range Over the Past 10 Years
Min: 16.69 Med: 20.21 Max: 47.17
Current: 47.17
During the past 6 years, Valiant Laboratories's highest Days Inventory was 47.17. The lowest was 16.69. And the median was 20.21.
NSE:VALIANTLAB's Days Inventory is ranked better than 94.65% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs NSE:VALIANTLAB: 47.17
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Valiant Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.59.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Valiant Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.49.
Valiant Laboratories (NSE:VALIANTLAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Valiant Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Valiant Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Valiant Laboratories Days Inventory Related Terms
Valiant Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Valiant Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:VALIANTLAB vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Valiant Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valiant Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Valiant Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Valiant Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valiant Laboratories (NSE:VALIANTLAB) has a Days Inventory of 57.47 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Valiant Laboratories and its competitors. This is 184% above median its historical median of 20.21. Over the past decade, Valiant Laboratories' Days Inventory has ranged from 16.69 to 47.17. According to the industry distribution chart, Valiant Laboratories ranks #49 out of 916 companies in the Drug Manufacturers industry, placing it in the top 5.3%.
Is Valiant Laboratories' Days Inventory too high?
Valiant Laboratories' current Days Inventory of 57.47 is 184% above median its 10-year median of 20.21. Over the past 10 years, this metric has ranged from a low of 16.69 to a high of 47.17. The Drug Manufacturers industry median Days Inventory is 164.43. Valiant Laboratories' value of 57.47 is 65% below this industry median. Based on the distribution chart, Valiant Laboratories ranks #49 out of 916 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Valiant Laboratories has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Valiant Laboratories' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Valiant Laboratories ranks #49 out of 916 companies for Days Inventory. This places Valiant Laboratories in the top 5% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.43. Valiant Laboratories' value of 57.47 is 65% below this benchmark. Historically, Valiant Laboratories' own Days Inventory has ranged from 16.69 to 47.17 over the past decade. While the company's 10-year median is 20.21 vs. the industry median of 164.43, Valiant Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Valiant Laboratories's current Days Inventory of 57.47 is 65% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Valiant Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valiant Laboratories's current Days Inventory is 57.47, which is 184% above median its own 10-year median of 20.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valiant Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Valiant Laboratories (NSE:VALIANTLAB) is currently considered Possible Value Trap. The stock's GF Value™ is ₹104.87, compared to a current price of ₹68.00 — trading 35.2% below its estimated fair value. The current Days Inventory is 57.47, which is 184% above median its 10-year median of 20.21 and 65% below the Drug Manufacturers industry median of 164.43. Valiant Laboratories' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Valiant Laboratories (NSE:VALIANTLAB), the current Days Inventory is 57.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Valiant Laboratories (NSE:VALIANTLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Valiant Laboratories stock appears to be undervalued.
The current stock price of ₹68.00 is trading 35.2% below its estimated GF Value™ of ₹104.87.
GuruFocus considers Valiant Laboratories to be Possible Value Trap.
Key valuation signals for NSE:VALIANTLAB:
Days Inventory: 57.47 (184% above median its 10-year median of 20.21)
GF Value™: ₹104.87 vs. price of ₹68.00 (35.2% below fair value)
Industry Position: 65% below the Drug Manufacturers median (#49 of 916)
No single metric tells the full story. See the NSE:VALIANTLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.
51GF Score
Get the complete analysis for NSE:VALIANTLAB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VALIANTLAB has been successfully added to your 
